Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-13 of 13 for your search:
Drug:
zorubicin hydrochloride
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Combination Chemotherapy with ARA-C/RBD/VCR/PRED for Adults with Chronic Myelogenous Leukemia
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
under 50
Sponsor:
Protocol IDs:
MDA-DT-7978
, NCI-V84-0021
2.
Phase II Chemotherapy with Rubidazone for Children with Refractory Acute Lymphoblastic or Acute Myelogenous Leukemia
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
under 21
Sponsor:
NCI
Protocol IDs:
POG-7818
, MDAR-313
3.
Phase II Chemotherapy with Rubidazone for Solid Tumors in Children
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
21 and under
Sponsor:
NCI
Protocol IDs:
POG-7843
4.
Phase II Combination Chemotherapy with Rubidazone and DTIC for Advanced Sarcomas and Mesotheliomas
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7625
, MDAR-134
5.
Phase II Combination Chemotherapy with ROAP - RBD/VCR/ARA-C/PRED for Acute Leukemia
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
over 50
Sponsor:
NCI
Protocol IDs:
SWOG-7626
6.
Phase II Chemotherapy with Rubidazone for Previously Treated Adults with Acute Leukemia or CML Blast Transformation
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
over 18
Sponsor:
NCI
Protocol IDs:
SWOG-7633
, MDAR-193
7.
Phase II Chemotherapy with Rubidazone for Advanced Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
65 and under
Sponsor:
NCI
Protocol IDs:
SWOG-7726
8.
Phase II Chemotherapy with Rubidazone for Lymphoma in Relapsing Patients Previously Untreated with Anthracycline Derivatives
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7734
9.
Phase II ROAP (RBD/VCR/ARA-C/PRED) vs ADOAP (ADR/VCR/ARA-C/PRED) with Intensification and/or Immunotherapy for Acute Leukemia
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
over 15
Sponsor:
NCI
Protocol IDs:
SWOG-7823/24/25/26
10.
Phase II Study of Rubidazone for Advanced Carcinomas of the Lung, Adenocarcinomas of the Pancreas and Colon, and Other Tumors
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
WSU-C-22877
11.
Phase II Chemotherapy with RBD vs ADR for Metastatic Breast Cancer in Previously Treated Patients
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-773201
12.
Induction by AZC/RBD and Maintenance by Repetitive Sequences of AZC/RBD, AZC/CTX, AZC/TG, AZC/VCR/DM for Acute Myelocytic Leukemia
Phase:
No phase specified
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
CLB-7703
13.
CROPAM Induction and ARA-C/6-TG Consolidation plus Autologous Bone Marrow Rescue and Antibiotics for Adult ALL, AUL, and LL
Phase:
No phase specified
Type:
Supportive care, Treatment
Status:
Closed
Age:
over 15
Sponsor:
Protocol IDs:
MDA-DT-7833
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Other Versions of this Site:
Mobile
|
Español
Follow Us:
Twitter
YouTube
Facebook
RSS
NIH…Turning Discovery Into Health
®